Clinical Trial Update: Study of Iodine-131 Anti-B1 Antibody for Patients With Non Hodgkin's Lymphoma Who Have Previously Received Rituximab [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update reporting results for an iodine-131 labeled anti-B1 antibody in Non-Hodgkin lymphoma patients who previously received rituximab; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Iodine-131 anti-B1 antibody (iodine-131 labeled anti-B1 antibody)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lymphoma, Non-Hodgkin | Phase 2 | Status: COMPLETED | Results posted: 2012-01-26